Protectus Medical Devices, Inc. Hires Award Winning Public Relations Firm, TransMedia Group, to Attract Media Attention for the Protectus Safety Syringe

MINNEAPOLIS, MN--(Marketwire - June 07, 2010) -

Highlighted Links

MacReport Media Publishing

Protectus Medical Devices

Protectus Medical Devices, Inc. ("Protectus Medical Devices") (OTCQB: PTMD), a developer and marketer of innovative medical devices, announced today that the Company has retained the services of award-winning public relations firm TransMedia Group (www.transmediagroup.com) as its national and international PR firm of record.

TransMedia Group's focus will be to garner publicity for the Protectus Safety Syringe. JP Hervis, Director of Public Relations at TransMedia (www.transmediagroup.com), said the firm, who has a stellar track record in promoting healthcare innovations, will present the Protectus Automatic Sheathing Hypodermic Syringe as the "gold standard for hypodermic safety syringes."

The Protectus Safety Syringe is the only fully automatic, self-sheathing safety hypodermic syringe that currently meets all U.S. Federal Government and OSHA mandates designed to protect both healthcare workers and patients alike. It is designed to significantly reduce or eliminate accidental needlestick injuries that have plagued the healthcare workplace for decades. More information about Protectus Medical Devices may be found at the Company's corporate website at www.protectusmedical.com.

TransMedia Group, headquartered in Boca Raton, Florida, was founded in New York City by Tom Madden, who was a high-ranking executive at the NBC Television Network and at American Broadcasting Companies in New York City prior to establishing the PR firm. The City of New York was one of the firm's first clients, for whom TransMedia created a program promoting fair housing that earned the firm a Bronze Anvil Award from The Public Relations Society of America. Since relocating the firm to Boca Raton, TransMedia has become one of Florida's largest, most distinguished public relations and marketing firms serving clients worldwide. TransMedia Group was recently named one of the top 100 companies by Leadership Magazine and is one of the oldest and largest independent PR firms in Florida serving clients worldwide since 1981. TMG is in lockstep with ever-changing trends of traditional media and the continued development and emergence of social media.

"After watching TransMedia's publicity catapult companies with innovative products from penny stocks onto major exchanges, we felt it would be the ideal firm to announce our breakthrough in syringe safety, the Protectus Automatic Self-Sheathing Safety Syringe," said Dr. John Salstrom, President and CEO of Protectus Medical Devices, Inc.

According to Hervis, TransMedia's PR campaign will present the Protectus Automatic Safety Syringe as the only one designed to meet all aspects of "Self-Sheathing" mandated by Federal Law passed to protect healthcare workers who are often pricked, scraped or injected by a needle before or after it has been injected and withdrawn from patients and therefore potentially carrying infectious blood-borne microorganisms.

"The Protectus Safety Syringe's spring-action sheath automatically covers the needle if the user ever loses control of the device," Hervis said. "The device has a user-friendly slide collar lock allowing the syringe to be used like any standard syringe, requiring little special training," he added.

The Company, managed and operated by pioneers in the development of safe and effective medical devices, has received 510(k) permission from the U.S. FDA to manufacture and market its patented safety syringe in the U.S. Federal legislation requiring healthcare employers to supply 'the best available safety devices,' similar to a California law mandating "Self-Sheathing Needles," was signed into law in the U.S. effective April 2001. Now, with the introduction of the Protectus safety syringe, hospitals and healthcare institutions can become fully compliant with this federal legislation.

About Protectus Medical Devices, Inc. (formerly, E-18 Corp.)

Protectus Medical Devices, Inc. (PTMD, formerly, E-18 Corp.), through its wholly owned subsidiary, SquareOne Medical, Inc., develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim. Protectus Medical Devices has successfully patented its automatic, self-sheathing hypodermic safety syringe product, and, based on the results of full comparison clinical trials, the Protectus Safety Syringe (formerly the SquareOne Safety Syringe) has received the required 510(k) permission from the U.S. FDA to manufacture and market the device in the U.S. More information about the Company may be found at www.protectusmedical.com.

Forward-Looking Statements

This release contains "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. These forward-looking statements are subject to various risks and uncertainties that could cause the business and financial results of Protectus Medical Devices, Inc. to differ materially from those currently anticipated, including the risk factors identified in Protectus Medical Devices, Inc.'s filings with the Securities and Exchange Commission.